Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business Sort ascending
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Business Sort ascending Area funzionale Data di pubblicazione
AS&T ekspert (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Set 09, 2024
QC Team Leader - Microbiology Tuas Bay Lane Singapore Operations Innovative Medicines Quality Ott 10, 2024
Quality Operations Coordinator İstanbul Kurtköy Turchia Operations Innovative Medicines Quality Ott 10, 2024
Specialist upravljanja kakovosti I – skladnost / QA Compliance Specialist I (m/f/d), Mengeš Mengeš Slovenia Operations Innovative Medicines Quality Ott 02, 2024
Quality Control Specialist İstanbul Kurtköy Turchia Operations Innovative Medicines Quality Ott 02, 2024
Specialist za analitiko v Centru za testiranje surovin (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 02, 2024
Quality Assurance Specialist II Carlsbad USA Operations Innovative Medicines Quality Ott 02, 2024
Site Quality Head, Indianapolis Isotopes Site Indianapolis USA Operations Innovative Medicines Quality Ott 02, 2024
Specialist-Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Ott 03, 2024
AS&T Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
QA Compliance Expert – Reg CMC Facilitator Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist - Product Complaints - QOP Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Analyst - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Quality Manager GCP / PV Hyderabad (Office) India Development Innovative Medicines Quality Set 03, 2024
Specialist Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Associate, QA Officer Operations Sasayama Giappone Operations Innovative Medicines Quality Set 03, 2024
Laboratorijski analitik v medfazni analitiki (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Ott 07, 2024
QC Specialist II (m/w/d), Schaftenau&Kundl, Tirol Schaftenau Austria Operations Innovative Medicines Quality Ott 07, 2024
Specialist upravljanja kakovosti za področje upravljanja kakovosti prostorov, opreme, HVAC sistemov in medijev (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 08, 2024
Specialist upravljanja kakovosti za podporo laboratorijem (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Ott 08, 2024
QC Chemist Indianapolis USA Operations Innovative Medicines Quality Ott 08, 2024
Specialist-Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Ott 08, 2024
Associate Director Data Ops & Analytics, RDQ Hyderabad (Office) India Development Innovative Medicines Quality Set 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Turchia Operations Innovative Medicines Quality Set 03, 2024
QC Specialist I - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
QC Specialist II - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA USP) Tuas South Avenue Singapore Operations Innovative Medicines Quality Set 03, 2024
GCP/PV Auditor Barcelona Provincial Spagna Operations Innovative Medicines Quality Ott 14, 2024
QA Operations Expert Kundl Austria Operations Innovative Medicines Quality Ott 14, 2024
Good Clinical Practices and Pharmacovigilance Sr. Auditor INSURGENTES Messico Operations Innovative Medicines Quality Ott 11, 2024
Global GMP Senior Quality Auditor Toronto Canada Operations Innovative Medicines Quality Ott 11, 2024
Senior GCP/PV Auditor Toronto Canada Operations Innovative Medicines Quality Ott 11, 2024
Global QMS RDQ Specialist Hyderabad (Office) India Development Innovative Medicines Quality Ott 13, 2024
Načrtovalec izvedbe laboratorijskih analiz (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 14, 2024
QA Specialist APQR INSURGENTES Messico Operations Innovative Medicines Quality Set 03, 2024
Compliance & Quality System Manager Ivrea Italia Operations Innovative Medicines Quality Ott 17, 2024
Investigation Expert Sasayama Giappone Operations Innovative Medicines Quality Ott 18, 2024
Quality Control Staff Sasayama Giappone Operations Innovative Medicines Quality Ott 18, 2024
Associate Manager - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 03, 2024
Quality Assurance Manager - QP/RP Amsterdam Paesi Bassi Operations Innovative Medicines Quality Set 17, 2024
Analyst Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 20, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Set 23, 2024
Expert Science & Technology, Microbiology (2nd Shift) East Hanover USA Development Innovative Medicines Quality Ott 10, 2024
Višji AS&T specialist (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Ott 10, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia